Trustco Bank Corp N Y

Most Recent

  • uploads///canopy
    Consumer

    Canopy Growth Stock Rises, Oppenheimer Initiates Coverage

    Oppenheimer analyst Rupesh Parikh initiated coverage on Canopy Growth stock. The analyst gave a “perform” rating with no target price.

    By Sushree Mohanty
  • uploads///Cannabis
    Cannabis

    Cannabis Sector 2019 Review and 2020 Outlook

    Canada legalized cannabis in October 2018, so investors expected 2019 to drive marijuana sales. However, the fate of the industry took a sharp turn.

    By Sushree Mohanty
  • uploads///marijuana
    Cannabis

    Marijuana Legalization: O’Rourke Blazes His 2020 Campaign

    Democratic presidential candidate Beto O’Rourke is known for voicing his opinion on federal marijuana legalization. He supports marijuana legalization.

    By Sushree Mohanty
  • uploads///
    Cannabis

    Cannabis Roundup: HEXO, WEED, ACB, and CTST

    The broader US markets were relatively flat today. Weakness in the cannabis sector continued, with the ETFMG Alternative Harvest ETF down 0.4%.

    By Rajiv Nanjapla
  • uploads///marijuana
    Cannabis

    Marijuana: Why Is Washington Changing Its Laws?

    In 2012, Washington was the second state to legalize recreational marijuana. Now, the state plans to revamp its marijuana laws.

    By Sushree Mohanty
  • uploads///canopy
    Cannabis

    Canopy Growth Gets an Upgrade, Constellation Books Losses

    Canopy Growth (CGC) (WEED) received optimistic views from analysts on Monday. Seaport Global Securities upgraded the stock to “buy” from “neutral.”

    By Sushree Mohanty
  • uploads///cannabis stocks
    Cannabis

    Which Cannabis Stocks Have Lost More than 40% in 2019?

    The cannabis industry has been on a rollercoaster ride this year. CannTrust, Tilray, and KushCo stocks have fallen more than 40% in 2019.

    By Sushree Mohanty
  • uploads///Forecast
    Consumer

    Considerations for Investors in Marijuana or Cryptocurrencies

    The forecasting of future cash flows depends on the market potential for legalized medical and recreational marijuana.

    By Adam Jones
  • uploads///cannabis
    Company & Industry Overviews

    Cannabis Stocks: Will Tough Times End Soon?

    Cannabis players are having a hard time this year. Regulatory concerns and weaker earnings due to the vaping-related crisis took a toll on the sector.

    By Sushree Mohanty
  • uploads///Cannabis
    Cannabis

    Cannabis Legalization: Dark Clouds Loom Post Debate

    Cannabis legalization is gaining traction not only in the US but also globally. The third presidential Democratic debate was held on September 12.

    By Sushree Mohanty
  • uploads///shelley pauls c_DvAfLs unsplash
    Cannabis

    The Next Big Breakout Beverage Market Has Been Identified

    Discover the under-the-radar Canadian company that is positioned to lead the upcoming wave of cannabis-infused beverages, BevCanna!

    By BevCanna
  • uploads///can_
    Cannabis

    Cannabis Sector Marks Third Straight Day of Decline

    The downward momentum in cannabis stocks has continued today, marking the third straight day of decline for the cannabis sector.

    By Rajiv Nanjapla
  • uploads///cannabis market
    Cannabis

    Did the Cannabis Sector Bottom Out in 2019?

    This year was tough for the cannabis sector, especially given that the S&P 500 was making new highs. The S&P 500 hit a new high of 3,247.93 on December 27.

    By Rajiv Nanjapla
  • uploads///canna_
    Cannabis

    Cannabis Update: HEXO, CTST, APHA, and ACB

    At 12:51 PM ET, the S&P 500 Index and the Dow Jones Industrial Average were up 0.5% and 0.7%, respectively. The cannabis sector was also up today.

    By Rajiv Nanjapla
  • uploads///cann
    Cannabis

    Cannabis Stocks in the Green: APHA, WEED, CTST, ACB

    With a boost from Aphria’s (APHA) impressive first-quarter earnings, cannabis stocks and ETFs were trading higher today. Let’s take a closer look.

    By Rajiv Nanjapla
  • uploads///HEXO
    Cannabis

    HEXO: The Next Cannabis Player on the Scandal Radar?

    By the end of September, HEXO was one of the few cannabis companies to have delivered positive returns in 2019. However, this month has been tough.

    By Rajiv Nanjapla
  • uploads///cannabis
    Cannabis

    Cannabis Scandal Radar: Is Tilray Next?

    Scandals have engulfed the sector many times, especially for CannTrust, Curaleaf, and Hexo. Could Tilray be next on the cannabis scandal radar?

    By Sushree Mohanty
  • uploads///CannTrust
    Cannabis

    CannTrust Stock Hits an All Time Low: What’s Next?

    CannTrust (CTST) (TRST) was one of the worst performers in the cannabis sector last week. The stock lost almost 19.6% in one week alone.

    By Adam Jones
  • uploads///
    Cannabis

    Cannabis Roundup: KSHB, WEED, CTST, and CURA

    Today, President Trump announced that a US-China trade deal could happen earlier than expected. Equities were up, but cannabis stocks were mixed.

    By Rajiv Nanjapla
  • uploads///cannabis
    Cannabis

    Cannabis: House to Vote on US Banking Bill

    The SAFE Banking Act is gaining traction again, as House Majority Leader Steny Hoyer is expected to bring the banking bill to the House floor for a vote.

    By Sushree Mohanty
  • uploads///CannTrust
    Cannabis

    CannTrust Loses License: Will It Fall below $1?

    CannTrust reported that its license under the Cannabis Act was suspended. The company won’t be able to produce cannabis. Will CannTrust fall below $1?.

    By Adam Jones
  • uploads///cannabis_
    Cannabis

    Cannabis Roundup: MMEN, ACB, WEED, and CTST

    Today at 2:10 PM ET, the S&P 500 Index fell 0.3% as investors watched rising oil prices. The cannabis sector also fell today, as its ETFs traded in the red.

    By Rajiv Nanjapla
  • uploads///CannTrust_
    Cannabis

    CannTrust: Eight Capital Removed Its Target Price

    On Tuesday, Eight Capital removed its target price for CannTrust Holdings due to uncertainty about the risks involved in the company’s future operations.

    By Rajiv Nanjapla
  • uploads///canntrust
    Cannabis

    CannTrust Down Almost 65% in 2019—What’s Next?

    On September 6, CannTrust Holdings (TRST) (CTST) was trading at 2.33 Canadian dollars. This marked a discount of 85% from its 52-week high.

    By Rajiv Nanjapla
  • uploads///cannabis
    Cannabis

    Cannabis Roundup: CTST, CRON, OGI, ACB, and WEED

    Cannabis ETFs the ETFMG Alternative Harvest ETF and the Horizons Marijuana Life Sciences Index ETF were up 2.0% and 1.7%, respectively, at 1:20 PM today.

    By Rajiv Nanjapla
  • uploads///HEXO
    Company & Industry Overviews

    HEXO: What’s the Word on the Street?

    HEXO stock has suffered since it reported lower-than-expected third-quarter results in June. The stock has fallen 31.8% since its earnings on June 12.

    By Sushree Mohanty
  • uploads///cannabis
    Cannabis

    Cannabis Legalization: Did President Trump Drop a Hint?

    Cannabis legalization is a hot topic. With the sudden boom in the cannabis industry, legalization at the national level is vital.

    By Sushree Mohanty
  • uploads///Cannabis ETFs
    Financials

    How Cannabis ETFs HMMJ, MJ, TOKE Looked in August

    In the wake of its regulatory scandals, the cannabis sector lagged the equity market in August. YTD, MJ and HMMJ have fallen 3.7% and 1.5%, respectively.

    By Rajiv Nanjapla
  • uploads///ogi
    Financials

    OrganiGram: Lower Target Price and Valuation Multiple

    Analysts expect OrganiGram to report revenues of 96.9 million Canadian dollars in fiscal 2019 and 206.5 million Canadian dollars in 2020.

    By Rajiv Nanjapla
  • uploads///Harris
    Cannabis

    Kamala Harris on Legalizing Marijuana and ‘MORE’

    Initially, Kamala Harris was against cannabis legalization. In 2010, she opposed Proposition 19 while serving as California’s attorney general.

    By Rajiv Nanjapla
  • uploads///CL
    Cannabis

    Cresco Labs: Target Price and Valuation Multiple

    Coverage on Cresco Labs has increased from seven analysts in July to nine in August. Six analysts favor a “strong buy,” and three recommend a “buy.”

    By Rajiv Nanjapla
  • uploads///Jim Cramer
    Cannabis

    HEXO: What Does Jim Cramer Think?

    HEXO reported its third-quarter earnings on June 12. The company reported revenues of $13.0 million, which fell short of analysts’ estimate.

    By Rajiv Nanjapla
  • uploads///
    Cannabis

    CannTrust: Why Has the Stock Fallen Today?

    CannTrust Holdings’ (TRST) troubles continue to rise. Today, OCS announced that it will return $2.9 million worth of products to the company.

    By Rajiv Nanjapla
  • uploads///Curaleaf
    Cannabis

    Why Has Curaleaf Lost 13.5% in August?

    As of August 17, Curaleaf Holdings (CURA) (CURLF) was trading at 9.00 Canadian dollars—a fall of 13.5% in August.

    By Rajiv Nanjapla
  • uploads///ACB
    Cannabis

    Aurora Cannabis’s Target Price and Valuation

    Despite Aurora Cannabis providing higher-than-expected guidance for fiscal 2019’s fourth quarter early this year, its stock has fallen 25.6% this month.

    By Rajiv Nanjapla
  • uploads///CTST
    Financials

    CannTrust: Current Target Price and Valuation Multiple

    As of Monday, CannTrust was trading at 3.04 Canadian dollars. The company has lost 53.6% of its stock value since the beginning of July.

    By Rajiv Nanjapla
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.